Study finds aspirin may reduce cancer risk, but it's not for everyone

the ONA take:

Guidelines from the Fred Hutchinson Cancer Research Center advise that low-dose daily aspirin for prevention of pancreatic cancer may not be for everyone. Although most researchers agree that long-term, low-dose aspirin has benefits for cardiovascular disease and cancer, the potential adverse effects of the drug include increased risk of bleeding in the stomach or the brain. In addition, the FDA warns against aspirin use to prevent a first heart attack or stroke. People at risk of pancreatic cancer should talk to their doctor about use of aspirin or any other preventive measures. The Center also warns people who abruptly stop taking the medication can increase risk of blood clots.

Study finds aspirin may reduce cancer risk, but it's not for everyone
Study finds aspirin may reduce cancer risk, but it's not for everyone
Many people use aspirin to prevent heart attack or stroke. Now, researchers say a low-dose of the over-the-counter medication can help fight against pancreatic cancer. A daily aspirin regime, according to a recent study, may reduce the risk of developing pancreatic cancer.
READ FULL ARTICLE From The Business Journals
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs